AXGN Q2 2024 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$48M+25.6% YoY

Gross Profit

$35M73.8% margin

Operating Income

-$428,000-0.9% margin

Net Income

-$2M-4.0% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+15.8%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$3M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$189M

Total Liabilities

$93M

Stockholders' Equity

$96M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$38M	+25.6%
Gross Profit	$35M	$30M	+19.2%
Operating Income	-$428,000	-$7M	+93.8%
Net Income	-$2M	-$7M	+71.2%